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Background & Aim: Visceral leishmaniasis (VL), or kala-azar caused by some species of 
Leishmania donovani complex, is endemic in southern Iran. The disease generally 
transmitted by the bite of female sand fly. A cross-sectional study was designed to 
determine the seroprevalence of VL among asymptomatic adult population in Meshkin-
Shahr area from north-west of Iran as an endemic focus of VL.  
Methods & Materials: A total of 180 blood samples were collected from asymptomatic 
adults‘ population during February 2015 to January 2016 for a period one year. Before 
sampling, a questionnaire was separately completed for each individual before the test. All 
the collected blood samples were examined by direct agglutination test (DAT) after plasma 
separation. Anti-Leishmania infantum antibodies at titers 1:100 to 1:1600 was considered 
as Leishmania infantum infection while, the cut-off titer of ≥1:3200 with specific signs and 
symptoms was considered as VL. 
Results: From 180 collected plasma samples, nine cases (5%) showed anti_Leishmania 
antibodies in at titers 1:400, 1:800, 1:1600. Two cases presented a titer of 1:400, four had 
a titer of 1:800 and three cases had a titer of 1:1600. All of seropositive cases were 
observed in females group and nobody had previous history of disease or remembered it in 
the past. 
The highest seropositivity rate was observed among age group of 13-23 years old. No 
changes in titers of anti-Leishmania antibodies observed after collected the seropositive 
blood samples again and tested by DAT with one month interval. 
Due to any apparent clinical symptoms has been observed in seropositive subjects, we 
resulted that subjects just contact with parasite but they don‘t get any active disease 
therefore the present investigation found asymptomatic subjects in study region.   
Conclusion: Visceral Leishmania infection is relatively high among adult people lived in 
Meshkin-Shahr area without any clinical symptoms. Asymptomatic VL infection is very 
important in immunocompromized individuals such as HIV-positive cases, these patients 
are at risk to manifesting clinical signs and symptoms of VL. Therefore continuing 
serological surveillance for detection of visceral Leishmania infection should be 
recommended in the endemic foci of VL. 
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